<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000285635"><TermName>etanercept</TermName><TermPronunciation>(ee-TA-ner-cept)</TermPronunciation><TermDefinition><DefinitionText>A drug that is commonly used to treat arthritis. It is also being studied in the treatment of cancer, and as a treatment for loss of appetite and weight loss in cancer patients. It belongs to the family of drugs called tumor necrosis factor (TNF) antagonists.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000710278" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;etanercept&quot;" language="en" id="_3"/><MediaLink ref="CDR0000710277" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;etanercept&quot;" language="es" id="_4"/><SpanishTermName>etanercept</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que generalmente se usa para tratar la artritis. También está en estudio para el tratamiento de cáncer y como tratamiento de la pérdida del apetito y la pérdida de peso en pacientes con cáncer. Es un tipo de antagonista del factor de necrosis tumoral (FNT).</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-02-21</DateFirstPublished><DateLastModified>2005-08-23</DateLastModified></GlossaryTerm>
